fda compounding semaglutide crackdown october 2025 National Hispanic Medical Association | After compounded GLP-1 drugs were banned, counterfeit versions continued to circulate — and still do today. Understanding the risks and FDA Intensifies Crackdown on GLP-1

Our programs are based on clinical research, not trends, giving residents reliable care

Lemme No

dialogue with other companies ongoing A new $299 savings offer, available from July 1 July 31, 2025, is designed to help new self-paying patients previously prescribed unapproved "semaglutide" start on FDA-approved Wegovy PLAINSBORO, N.J., June 26, 2025 /PRNewswire/ -- Novo Nordisk continues expansion of patient access to Wegovy (semaglutide) injection 2.4 mg through a new collaboration with WeightWatchers, a global leader in science-backed weight management, beginning July 1, 2025

The human studies that do exist are typically small (often fewer than 100 participants), short in duration (commonly eight to twelve weeks), and methodologically inconsistent, with significant heterogeneity in dosing, formulation, and outcome measures

If a dose is missed, patients should administer it as soon as possible if fewer than four days (96 hours) have passed since the missed dose

Follow-up appointments will monitor your progress and adjust treatment as needed